Outcome of routine cerebrospinal fluid screening for enterovirus and human parechovirus infection among infants with sepsis-like illness or meningitis in Cornwall, UK
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Enteroviruses (EV) and human parechoviruses (HPeV) are known and emerging cause of sepsis-like illnesses in infants; however, testing is not yet routine. We retrospectively evaluated the number of diagnosed EV/HPeV infections in children under the age of 5 years who presented with sepsis-like illness or meningitis in Cornwall, UK, before and after routine implementation of viral screening of cerebrospinal fluid samples. During the 4-year period prior to routine testing, we identified 20 cases of EV meningitis and no cases of HPeV. In the year after introduction of routine screening, 27 cases of EV and 14 cases of HPeV were identified in 1 year. The majority of EV/HPeV infections occurred among children under 3 months old between May and August. Clinical and laboratory characteristics of EV and HPeV infections were mostly indistinguishable. We found that CSF pleocytosis and biochemistry-based testing strategy could miss 48.1 and 78.5% of EV and HPeV cases, respectively. With routine viral screening, the mean length of hospital stay (3.8 vs 5.9 days, P Conclusion Routine EV and HPeV testing of CSF samples in children has the potential to reduce length of stay and antibiotic use. What is Known: • EV and HPeV are frequent cause of meningitis and sepsis-like illness among young children. • There is increasing evidence supporting routine EV and HPeV testing of paediatric CSF. What is New: • Outcome of routine EV and HPeV testing in Cornwall, UK. • The value of testing all paediatri…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Previous studies have shown that rapid PCR testing of CSF can reduce unnecessary antimicrobial use and shorten hospital stays1, 4.”
From Clinical Impact of Cerebrospinal Fluid Multiplex Polymerase Chain Reaction (PCR) Testing in Children with Suspected Central Nervous System Infection (2025) · cites this paper as [4]
In the citing paper
“in pediatric patients with a positive CSF EV PCR result, the duration of IV antibiotic therapy was shortened by a median of 1.5 days, hospital stay decreased from 71.5 to 42 hours, and discharge occurred about 5 hours after the result became available.”
From Clinical Impact of Cerebrospinal Fluid Multiplex Polymerase Chain Reaction (PCR) Testing in Children with Suspected Central Nervous System Infection (2025) · cites this paper as [4]
In the citing paper
“In contrast, PCR-negative or untested patients often received longer empirical treatment4.”
From Clinical Impact of Cerebrospinal Fluid Multiplex Polymerase Chain Reaction (PCR) Testing in Children with Suspected Central Nervous System Infection (2025) · cites this paper as [4]
In the citing paper
“Molecular diagnostic tests based on polymerase chain reaction (PCR) -particularly multiplex PCR panels- allow rapid and reliable identification of multiple neurotropic pathogens in CSF samples.”
From Clinical Impact of Cerebrospinal Fluid Multiplex Polymerase Chain Reaction (PCR) Testing in Children with Suspected Central Nervous System Infection (2025) · cites this paper as [4]
In the citing paper
“This approach can lead to unnecessary prolonged use of antibiotics or acyclovir, longer hospital stays, and increased healthcare costs, especially in cases that ultimately prove to be benign viral infections4.”
From Clinical Impact of Cerebrospinal Fluid Multiplex Polymerase Chain Reaction (PCR) Testing in Children with Suspected Central Nervous System Infection (2025) · cites this paper as [4]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Enteroviral infections of the central nervous system.
Rotbart, H. A. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.4.971 · Cited by 312
Benschop, K. S. M., Schinkel, J., Minnaar, R. P., Pajkrt, D., Spanjerberg, L., Kraakman, H. C., Berkhout, B., Zaaijer, H. L., Beld, M. G. H. M., & Wolthers, K. C. (2006) · Clinical Infectious Diseases · doi:10.1086/498905 · Cited by 261
Wolthers, K. C., Benschop, K. S. M., Schinkel, J., Molenkamp, R., Bergevoet, R. M., Spijkerman, I. J. B., Kraakman, H. C., & Pajkrt, D. (2008) · Clinical Infectious Diseases · doi:10.1086/589752 · Cited by 252
Khetsuriani, N., LaMonte, A., Oberste, M. S., & Pallansch, M. (2006) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000237798.07462.32 · Cited by 207
Harvala, H., Robertson, I., Chieochansin, T., McWilliam Leitch, E. C., Templeton, K., & Simmonds, P. (2009) · The Journal of Infectious Diseases · doi:10.1086/599094 · Cited by 182
Parechovirus Encephalitis and Neurodevelopmental Outcomes
Britton, P. N., Dale, R. C., Nissen, M. D., Crawford, N., Elliott, E., Macartney, K., Khandaker, G., Booy, R., Jones, C. A., & on behalf of the PAEDS-ACE Investigators (2016) · Pediatrics · doi:10.1542/peds.2015-2848 · Cited by 144
Pediatric parechovirus infections
Esposito, S., Rahamat-Langendoen, J. C., Ascolese, B., Senatore, L., Castellazzi, L., & Niesters, H. G. M. (2014) · Journal of Clinical Virology · doi:10.1016/j.jcv.2014.03.003 · Cited by 140
Harvala, H., McLeish, N., Kondracka, J., McIntyre, C. L., McWilliam Leitch, E. C., Templeton, K., & Simmonds, P. (2011) · Journal of Medical Virology · doi:10.1002/jmv.22023 · Cited by 112
Characteristics and outcomes of human parechovirus infection in infants (2008–2012)
Vergnano, S., Kadambari, S., Whalley, K., Menson, E., Martinez-Alier, N., Cooper, M. K., Sanchez, E., Heath, P. T., & Lyall, H. (2015) · European Journal of Pediatrics · doi:10.1007/s00431-014-2483-3 · Cited by 70
Human Parechovirus Infection, Denmark
Fischer, T. K., Midgley, S., Dalgaard, C., & Nielsen, A. Y. (2014) · Emerging Infectious Diseases · doi:10.3201/eid2001.130569 · Cited by 70
Harvala, H., Griffiths, M., Solomon, T., & Simmonds, P. (2014) · Journal of Infection · doi:10.1016/j.jinf.2014.02.017 · Cited by 69
Mulford, W. S., Buller, R. S., Arens, M. Q., & Storch, G. A. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.9.4199-4203.2004 · Cited by 68
Janes, V. A., Minnaar, R. P., Koen, G., van Eijk, H. W. M., de Haan, K., Pajkrt, D., Wolthers, K. C., & Benschop, K. (2014) · Eurosurveillance · doi:10.2807/1560-7917.es2014.19.46.20964 · Cited by 60
Piralla, A., Mariani, B., Stronati, M., Marone, P., & Baldanti, F. (2014) · Early Human Development · doi:10.1016/s0378-3782(14)70023-4 · Cited by 57
Parechovirus Genotype 3 Outbreak among Infants, New South Wales, Australia, 2013–2014
Cumming, G., Khatami, A., McMullan, B. J., Musto, J., Leung, K., Nguyen, O. T. K., Ferson, M. J., Papadakis, G., & Sheppeard, V. K. (2015) · Emerging infectious diseases · doi:10.3201/eid2107.141149 · Cited by 48
Kadambari, S., Bukasa, A., Okike, I. O., Pebody, R. G., Brown, D. W., Gallimore, C. I., Xerry, J., Sharland, M., & Ladhani, S. N. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12753 · Cited by 47
Human Parechovirus in Respiratory Specimens from Children in Kansas City, Missouri
Sharp, J., Bell, J., Harrison, C. J., Nix, W. A., Oberste, M. S., & Selvarangan, R. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.01680-12 · Cited by 38
Clinical relevance of positive human parechovirus type 1 and 3 PCR in stool samples
Wildenbeest, J., Wildenbeest, J., Benschop, K., Minnaar, R. P., Jongh, S. B.-D., Wolthers, K. C., Pajkrt, D., Benschop, K. S. M., Minnaar, R. P., Jongh, S. B.-D., et al. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12542 · Cited by 32
Tang, J. W.-T., Holmes, C. W., Elsanousi, F., Patel, A., Adam, F., Speight, R., Shenoy, S., Bronnert, D., Stiefel, G., Sundaram, P., et al. (2016) · Eurosurveillance · doi:10.2807/1560-7917.es.2016.21.34.30326 · Cited by 25
Cited by
World-Wide Prevalence and Genotype Distribution of Enteroviruses
Brouwer, L., Moreni, G., Wolthers, K. C., & Pajkrt, D. (2021) · Viruses · doi:10.3390/v13030434 · Cited by 127
Viral Infections and the Neonatal Brain
de Vries, L. S. (2019) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2019.08.005 · Cited by 102
van Hinsbergh, T. M. T., Elbers, R. G., Ket, J. C. F., van Furth, A. M., & Obihara, C. C. (2020) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(20)30181-4 · Cited by 51
NICE guideline review: fever in under 5s: assessment and initial management (NG143)
Paul, S. P., Kini, P. K., Tibrewal, S. R., & Heaton, P. A. (2021) · Archives of Disease in Childhood Education & Practice · doi:10.1136/archdischild-2021-321718 · Cited by 28
de Ceano-Vivas, M., García, M. L., Velázquez, A., Martín del Valle, F., Menasalvas, A., Cilla, A., Epalza, C., Romero, M. P., Cabrerizo, M., & Calvo, C. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.719119 · Cited by 22
“9%) (10), and may be clinically indistinguishable (11, 12); however, some studies including Black et al.”
Background
Metadata
- Authors
- Chakrabarti, P., Warren, C., Vincent, L., & Kumar, Y.
- Affiliations
- Royal Cornwall Hospital Trust (GB)
- Royal Cornwall Hospital (GB)
- Corresponding author
- Chakrabarti, Prithwiraj
- Venue
- European Journal of Pediatrics
- Published
- 2018-07-18
- Volume
- 177
- Issue
- 10
- Pages
- 1523-1529
- ISSN
- 0340-6199 (ISSN-L)
- 1432-1076
- OpenAlex
- W2884841498
- Cited by
- 31
- References
- 19
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 1 · 2023: 4 · 2022: 2 · 2021: 9 · 2020: 6 · 2019: 5
- FWCI
- 3.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- European Journal of Pediatrics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Yadlapalli Kumar (Research fund)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal and Maternal Infections
- Health Sciences › Medicine › Infectious Diseases › Infectious Encephalopathies and Encephalitis
- Keywords
- enterovirus, human parechovirus, sepsis-like illness, meningitis, infants, length of hospital stay, antibiotic use, cerebrospinal fluid pleocytosis, diagnostic yield, seasonal occurrence
- MeSH terms
- Anti-Bacterial Agents, Cerebrospinal Fluid, Child, Preschool, Enterovirus Infections, Enterovirus, Female, United Kingdom, Humans, Infant, Infant, Newborn, Length of Stay, Male, Mass Screening, Meningitis, Viral, Picornaviridae Infections, Retrospective Studies, Prevalence, Polymerase Chain Reaction, Sepsis, Parechovirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.